• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.33% Nasdaq Up 1.33%

    More On NVGN

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Novogen Limited (NVGN)

    -NasdaqCM
    1.87 Down 0.04(2.09%) 3:59PM EDT
    Prev Close:1.91
    Open:1.92
    Bid:N/A
    Ask:2.15 x 400
    1y Target Est:5.00
    Beta:0.61808
    Next Earnings Date:N/A
    Day's Range:1.87 - 1.92
    52wk Range:1.79 - 5.35
    Volume:22,706
    Avg Vol (3m):30,831
    Market Cap:32.14M
    P/E (ttm):N/A
    EPS (ttm):-0.45
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.78
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jun-16) :N/A
    Quarterly EPS Est (0-00-31) :N/A
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novogen Limited engages in the pharmaceutical research and development business in Australia. The company primarily has two drug technology platforms, which include superbenzopyran (SBPs) and anti-tropomyosin (ATMs). View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback